Surgery for Mental Ills Offers Hope and Risk
International Herald Tribune - Thu Nov 26, 10:35 pm ETMore than 500 people have undergone brain surgery for problems like depression, anxiety, Tourette’s syndrome, even obesity, most in studies.
4992 Stories, most recent news story added Wed Nov 25, 1:15 am ET
More than 500 people have undergone brain surgery for problems like depression, anxiety, Tourette’s syndrome, even obesity, most in studies.
The U.S. Food and Drug Administration (FDA) is seeking a permanent injunction against Sharkco Seafood International Inc., located in Venice, La. The injunction is intended to stop the seafood processing company from distributing scombrotoxin-forming fish in interstate commerce. Consumption of scombrotoxin-forming fish that are not properly preserved or refrigerated can result in scombroid food ...
Hedge funds, Wall Street, SEC and FDA out to hurt maker of flu drug, newsletter writer claims.
The FDA wants pet food manufacturers to list common color additives on animal food labels.
Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration has accepted for review Eisai's New Drug Application for once daily 23 mg Aricept® tablets for the treatment of moderate to severe Alzheimer's disease .
With money market funds and savings accounts paying virtually nothing, it's time to look at high-dividend stocks and other slightly more risky investments.
Our view on food safety: How many sick school kids kids does it take to get FDA regulators to act? Tortilla case illustrates what’s wrong with food inspection system. In October 2003, inspectors from the Food and Drug Administration went...
Gen-Probe Incorporated announced today that the US Food and Drug Administration has cleared for marketing Prodesse's ProParaflu+ assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections.
Two dairy farms in St. Lawrence County were issued warning letters by the Food and Drug Administration earlier in the year. The warnings were revealed last week on the FDA website. The Adon farm in Potsdam was inspected in April and a warning letter was issued in August. The FDA said the farm offered an animal for slaughter that exceeded the tolerance for residues of penicillin. The Lloyd Smith ...
MONDAY, Nov. 23 (HealthDay News) -- Problems with the popular arthritis drug Vioxx, including increased risk for heart attack, stroke and death, were known for years before the drug's voluntary withdrawal from the market in 2004, a new report says.
The fall meeting of the Board of Directors of the American Feed Industry Association occurred in Indianapolis, IN, Nov. 11-12. AFIA Chairman Brian Rittgers , national sales manager of the dairy business unit of Elanco Animal Health of Greenfield, IN, presided.
Tulane University School of Medicine surgeon Dr. Emad Kandil is one of the first in the country to perform a new form of endoscopic surgery that uses a small incision under the arm to remove all or a portion of the thyroid or parathyroid glands without leaving a scar on the neck.
By: Tim Naida The Food and Drug Administration is considering banning caffeinated alcoholic beverages, leaving many to wonder what the effect on students and local businesses may be....
Nov 24, 2009 (CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.
WILMINGTON, Del.----Incyte Corporation announced today that it has entered into a collaboration and license agreement with Novartis for two of its investigational hematology-oncology therapies: INCB18424, an oral JAK1/JAK2 inhibitor that is in Phase III development for myelofibrosis, a serious life-threatening neoplastic condition characterized by varying degrees of bone marrow failure, splenic ...
British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S. approval of a drug to prevent prostate cancer.